catalinagarcia
0 POSTS0 COMMENTS
Mesothelin, also known as MSLN, is an attractive target for cancer immunotherapy, especially for adoptive T-cell therapy. MSLN is highly expressed in a broad spectrum of solid tumors including mesothelioma, lung cancer, pancreatic cancer, breast cancer, and ovarian cancer and so on while with the exception of normal mesothelia cells. Learn more: anti-MSLN CAR-T in vivo assay
No posts to display
TOP AUTHORS
- Advertisment -